The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.
Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
FluMist is a live-attenuated influenza vaccine. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug ...
Iqirvo is available for oral administration as round, orange-coloured, film-coated tablets in a dosage strength of 80mg. Iqirvo is a PPAR agonist indicated for the treatment of PBC in adults. Credit: ...
Graphene provides several advantages over traditional materials, according to the surgeon who performed the procedure. Image credit: Shutterstock/ Production Perig. InBrain Neuroelectronics’ ...
The Phase III HARMONY Study was initiated in December last year. Credit: PeopleImages.com – Yuri A/Shutterstock. Travere Therapeutics has voluntarily paused subject enrolment in the Phase III HARMONY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback